Additionally, Rotterlin, a protein kinase inhibitor that exerts its anti-tumor activity in various types of human cancers, was found to upregulate DDX3X expression in HCC that subsequently downregulates cyclin D1 expression and increases p21 level, leading to cell cycle arrest [34]. Here, DDX3X is linked to cancer.